Mission Statement

Despite Nuclear Medicine’s role in personalized medicine and the potential it offers with its diagnostic and therapeutic opportunities, it remains a complex discipline to be explained to all stakeholders. Very few people are aware of all the workings of this technique. Moreover, even less know about the high potential of radiolabeled molecules in therapeutic applications, which may change the way of treating cancer patients in the very near future.

The Nuclear Medicine Europe Communications Working Group’s mission is to communicate most efficiently all relevant information regarding Nuclear Medicine and Molecular Imaging industry to all stakeholders and influencers, such as the European Union Parliament, the European Union Commission, EU governments, national and international pharmaceutical agencies, physicians, patient groups and the public in general. Nuclear Medicine Europe, through this Working Group, will also provide accurate scientific information to journalists who will relay it to the press.

The Working Group will be responsible for optimizing messages and selecting the right media for each occasion. The context of such communications will come from the different Nuclear Medicine Europe Working Groups, external consultants, and partners. The Group will also participate in the organization of the annual Nuclear Medicine Europe Symposium.

The Group will support educational activities and may create together with assigned experts teaching materials for the Nuclear Medicine Europe related communities: patients, medical/nuclear physicians and decision-makers/influencers. 


• Digital Assets 
A webpage offering digital assets specifically designed for Nuclear Medicine Europe Members and trusted Partners, promoting collaboration across various communication channels. We encourage their careful and respectful use to reflect our shared values and advance the field of nuclear medicine for global healthcare impact.

• What Is Nuclear Medicine.com
A comprehensive online resource providing detailed insights into the field of nuclear medicine, offering educational materials, latest research updates, and patient information. With a user-friendly interface and expertly curated content, it serves as a valuable platform for both professionals and individuals seeking to understand the applications and benefits of nuclear medicine in healthcare.

The Group

Chair (ad-interim): David Crunelle
Sr. Communications Advisor – Nuclear Medicine Eurorpe

Co-Chair: Pascal Daniel

Marketing Director Europe, SPECT International – Curium Group

Supervisor: Mart-Jan Blauwhoff
Scientific Marketing Director – Curium Group

Alkim Aydin
Marketing Manager – Monrol

Bérénice Pignol
Marketing & Communication Manager – IRE

Paweł Bombik
Marketing Specialist

Jean-Michel Geets
Integralab Business Developer – IBA

Jean-François Gestin

Fabrice Giaccomelli
CEO – Nucleis

Clare Gidley
Associate Director Marketing and Communications – Blue Earth Diagnostics

Dimitry Ginzburg
R&D Manager – Rotem

Ira Goldman
Vice President, Global Public Policy and Government Relations – Lantheus

Antonis Kalemis
Head of Collaborations & Physics Molecular Imaging, EMEA  – Siemens-Healthineers

Sophie Letournel
Governance and Communication Director – Oranomed

Simone Leyden
Director Global Patient Advocacy and Government Affairs –  Telix Pharmaceuticals

Etienne Boquien
Global Product Leader Core Molecular Imaging – GE Healthcare

Jan Schöpflin
Head of Marketing – Eckert & Ziegler

Jasminka Taleska

Nick den Hartog

Giorgia Gurioli
Events and Partners Coordinator
Tema Sinergie

Francetta Carr
Serac Life Sciences

Shopping Basket